Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
On June 20, 2024, Michael A. Choti, MD, MBA, Banner MD Anderson, co-chaired the second annual Advancing Worth-Primarily based Oncology Care assembly in...
This examine investigated the affect of adjustments in well being conduct on the danger of mortality amongst most cancers survivors. First, cox proportional-hazards...
